Key points are not available for this paper at this time.
Depression and general medical health care expenditures increase with the degree of treatment-resistant depression. Disease management interventions for treatment-resistant depression that result in sustained remission early in the course of illness are most likely to be cost effective.
Russell et al. (Mon,) studied this question.